Edition:
United States

PureTech Health PLC (PTCHF.PK)

PTCHF.PK on OTC Markets Group - US Other OTC and Grey Market

1.78USD
19 Sep 2017
Change (% chg)

$0.03 (+1.71%)
Prev Close
$1.75
Open
$1.78
Day's High
$1.78
Day's Low
$1.78
Volume
1,000
Avg. Vol
4,074
52-wk High
$2.05
52-wk Low
$1.40

Chart for

About

PureTech Health plc is a cross-disciplinary healthcare company. The Company operates through two segments: growth stage businesses and project phase businesses. Businesses in the growth stage businesses segment are those whose activities focus on developing products to solve healthcare problems in varied markets. This segment... (more)

Overall

Beta: --
Market Cap(Mil.): £322.28
Shares Outstanding(Mil.): 237.43
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 80.15 16.18
EPS (TTM): -- -- --
ROI: -- 3.01 14.60
ROE: -- 4.76 13.87

BRIEF-PureTech initiates phase 2b inhibitors study in respiratory tract infections

* Announces initiation of phase 2b mtorc1 inhibitors study in elderly patients at increased risk of respiratory tract infections

May 09 2017

BRIEF-PureTech Health launches new immuno-oncology programme

* Advances new programme targeting immunosuppressive gamma delta t cells and related mechanisms

Apr 11 2017

BRIEF-PureTech Health's Akili announces pilot study results

* Results from project EVO pilot study showed improved cognitive control in children with sensory processing dysfunction, attentional deficits Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

Apr 06 2017

Earnings vs. Estimates